Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group

被引：178

作者：

Averbuch, Diana ^{[1
]}

Tridello, Gloria ^{[2
]}

Hoek, Jennifer ^{[3
]}

Mikulska, Malgorzata ^{[4
]}

Akan, Hamdi ^{[5
]}

Yanez San Segundo, Lucrecia ^{[6
]}

Pabst, Thomas ^{[7
]}

Ozcelik, Tulay ^{[8
]}

Klyasova, Galina ^{[9
]}

Donnini, Irene ^{[10
]}

Wu, Depei ^{[11
]}

Gulbas, Zafer ^{[12
]}

Zuckerman, Tsila ^{[13
]}

de Sousa, Aida Botelho ^{[14
]}

Beguin, Yves ^{[15
]}

Xhaard, Alienor ^{[16
]}

Bachy, Emmanuel ^{[17
]}

Ljungman, Per ^{[18
,19
]}

de la Camara, Rafael ^{[20
]}

Rascon, Jelena ^{[21
]}

Ruiz Camps, Isabel ^{[22
]}

Vitek, Antonin ^{[23
]}

Patriarca, Francesca ^{[24
]}

Cudillo, Laura ^{[25
]}

Vrhovac, Radovan ^{[26
]}

Shaw, Peter J. ^{[27
]}

Wolfs, Tom ^{[28
]}

O'Brien, Tracey ^{[29
]}

Avni, Batia ^{[1
]}

Silling, Gerda ^{[30
]}

Al Sabty, Firas ^{[31
]}

Graphakos, Stelios ^{[32
]}

Sankelo, Marja ^{[33
]}

Sengeloev, Henrik ^{[34
]}

Pillai, Srinivas ^{[35
]}

Matthes, Susanne ^{[36
]}

Melanthiou, Frederiki ^{[37
]}

Iacobelli, Simona ^{[25
]}

Styczynski, Jan ^{[38
]}

Engelhard, Dan ^{[1
]}

Cesaro, Simone ^{[2
]}

机构：

[1] Hadassah Univ Hosp, Jerusalem, Israel

[2] Azienda Osped Univ Integrata, Pediat Hematol Oncol, Verona, Italy

[3] European Bone Marrow Transplantat Data Off, Leiden, Netherlands

[4] Osped San Martino Genova, Genoa, Italy

[5] Ankara Univ, Fac Med, Ankara, Turkey

[6] Hosp Univ Marques de Valdecilla, Santander, Spain

[7] Univ Hosp, Bern, Switzerland

[8] Florence Nightingale Sisli Hosp, Istanbul, Turkey

[9] Natl Res Ctr Hematol, Moscow, Russia

[10] Azienda Osped Univ Careggi, Florence, Italy

[11] Soochow Univ, Affiliated Hosp 1, Suzhou, Jiangsu, Peoples R China

[12] Anadolu Med Ctr Hosp, Kocaeli, Turkey

[13] Rambam Med Ctr, Haifa, Israel

[14] Hosp Capuchos, Lisbon, Portugal

[15] Univ Liege, Liege, Belgium

[16] Hosp St Louis, Paris, France

[17] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Lyon, France

[18] Karolinska Univ Hosp, Stockholm, Sweden

[19] Karolinska Inst, Stockholm, Sweden

[20] Hosp Princesa, Madrid, Spain

[21] Univ Hosp Santariskiu Klinikos, Vilnius, Lithuania

[22] Hosp Valle De Hebron, Barcelona, Spain

[23] Inst Hematol & Blood Transfus, Prague, Czech Republic

[24] Azienda Osped Univ, Udine, Italy

[25] Tor Vergata Univ, Rome, Italy

[26] Univ Hosp Ctr Rebro, Zagreb, Croatia

[27] Childrens Hosp, Westmead, NSW, Australia

[28] Univ Hosp Children, Utrecht, Netherlands

[29] Sydney Childrens Hosp, Randwick, NSW, Australia

[30] Univ Munster, Munster, Germany

[31] Univ Hosp, Bratislava, Slovakia

[32] St Sophia Childrens Hosp, Athens, Greece

[33] Tampere Univ Hosp, Tampere, Finland

[34] Rigshosp, Copenhagen, Denmark

[35] Univ Hosp North Staffordshire, Stoke On Trent, England

[36] St Anna Childrens Hosp, Vienna, Austria

[37] Nicosia Gen Hosp, Nicosia Strovolos, Cyprus

[38] Nicolaus Copernicus Univ Torun, Coll Med, Bydgoszcz, Poland

来源：

CLINICAL INFECTIOUS DISEASES | 2017年 / 65卷 / 11期

关键词：

antimicrobial resistance; gram-negative rods; hematopoietic stem cell transplantation; bacteremia; BLOOD-STREAM INFECTIONS; NEUTROPENIC PATIENTS; KLEBSIELLA-PNEUMONIAE; RISK-FACTORS; MULTICENTER; CARBAPENEM; CANCER; ENTEROBACTERIACEAE; PROPHYLAXIS; THERAPY;

D O I：

10.1093/cid/cix646

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Data from a prospective intercontinental study of resistance in gram-negative rods causing bacteremia in hematopoietic stem cell transplant recipients challenge current approach to fluoroquinolone prophylaxis and call for reassessment of local empiric antibiotic protocols. Knowledge of pathogen-specific resistances enables early appropriate empiric therapy.This intercontinental study aimed to study gram-negative rod (GNR) resistance in hematopoietic stem cell transplantation (HSCT). GNR bacteremias occurring during 6 months post-HSCT (February 2014-May 2015) were prospectively collected, and analyzed for rates and risk factors for resistance to fluoroquinolones, noncarbapenem anti-Pseudomonas beta-lactams (noncarbapenems), carbapenems, and multidrug resistance. Sixty-five HSCT centers from 25 countries in Europe, Australia, and Asia reported data on 655 GNR episodes and 704 pathogens in 591 patients (Enterobacteriaceae, 73%; nonfermentative rods, 24%; and 3% others). Half of GNRs were fluoroquinolone and noncarbapenem resistant; 18.5% carbapenem resistant; 35.2% multidrug resistant. The total resistance rates were higher in allogeneic HSCT (allo-HSCT) vs autologous HSCT (auto-HSCT) patients (P < .001) but similar in community-acquired infections. Noncarbapenem resistance and multidrug resistance were higher in auto-HSCT patients in centers providing vs not providing fluoroquinolone prophylaxis (P < .01). Resistance rates were higher in southeast vs northwest Europe and similar in children and adults, excluding higher fluoroquinolone- and beta-lactam/beta-lactamase inhibitor resistance rates in allo-HSCT adults. Non-Klebsiella Enterobacteriaceae were rarely carbapenem resistant. Multivariable analysis revealed resistance risk factors in allo-HSCT patients: fluoroquinolone resistance: adult, prolonged neutropenia, breakthrough on fluoroquinolones; noncarbapenem resistance: hospital-acquired infection, breakthrough on noncarbapenems or other antibiotics (excluding fluoroquinolones, noncarbapenems, carbapenems), donor type; carbapenem resistance: breakthrough on carbapenem, longer hospitalization, intensive care unit, previous other antibiotic therapy; multidrug resistance: longer hospitalization, breakthrough on beta-lactam/beta-lactamase inhibitors, and carbapenems. Inappropriate empiric therapy and mortality were significantly more common in infections caused by resistant bacteria. Our data question the recommendation for fluoroquinolone prophylaxis and call for reassessment of local empiric antibiotic protocols. Knowledge of pathogen-specific resistance enables early appropriate empiric therapy. Monitoring of resistance is crucial. NCT02257931.

引用

页码：1819 / 1828

页数：10

共 39 条

[1] Non-fermentative Gram-negative rods bacteremia in children with cancer: a 14-year single-center experience
Averbuch, D.
Avaky, C.
Harit, M.
Stepensky, P.
Fried, I.
Ben-Ami, T.
Temper, V.
Peled, Y.
Troen, H.
Masarwa, R.
Abu Ahmad, W.
Weintraub, M.
Revel-Vilk, S.
Engelhard, D.
[J]. INFECTION, 2017, 45 (03) : 327 - 334
[2] European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia
Averbuch, Diana
Orasch, Christina
Cordonnier, Catherine
Livermore, David M.
Mikulska, Malgorzata
Viscoli, Claudio
Gyssens, Inge C.
Kern, Winfried V.
Klyasova, Galina
Marchetti, Oscar
Engelhard, Dan
Akova, Murat
[J]. HAEMATOLOGICA, 2013, 98 (12) : 1826 - 1835
[3] Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011)
Averbuch, Diana
Cordonnier, Catherine
Livermore, David M.
Mikulska, Malgorzata
Orasch, Christina
Viscoli, Claudio
Gyssens, Inge C.
Kern, Winfried V.
Klyasova, Galina
Marchetti, Oscar
Engelhard, Dan
Akova, Murat
[J]. HAEMATOLOGICA, 2013, 98 (12) : 1836 - 1847
[4] Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations
Blennow, O.
Ljungman, P.
Sparrelid, E.
Mattsson, J.
Remberger, M.
[J]. TRANSPLANT INFECTIOUS DISEASE, 2014, 16 (01) : 106 - 114
[5] Bacteremia in Blood or Marrow Transplantation Patients: Clinical Risk Factors for Infection and Emerging Antibiotic Resistance
Bock, Allison M.
Cao, Qing
Ferrieri, Patricia
Young, Jo-Anne H.
Weisdorf, Daniel J.
[J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (01) : 102 - 108
[6] An 8-year survey of strains identified in blood cultures in a clinical haematology unit
Bousquet, A.
Malfuson, J-V
Sanmartin, N.
Konopacki, J.
MacNab, C.
Souleau, B.
de Revel, T.
Elouennass, M.
Samson, T.
Soler, C.
Foissaud, V.
Martinaud, C.
[J]. CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (01) : O7 - O12
[7] Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia
Bucaneve, G
Micozzi, A
Menichetti, F
Martino, P
Dionisi, MS
Martinelli, G
Allione, B
D'Antonio, D
Buelli, M
Nosari, AM
Cilloni, D
Zuffa, E
Cantaffa, R
Specchia, G
Amadori, S
Fabbiano, F
Deliliers, GL
Lauria, F
Foà, R
Del Favero, A
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (10) : 977 - 987
[8] Multidrug resistant Pseudomonas aeruginosa infection in children undergoing chemotherapy and hematopoietic stem cell transplantation
Caselli, Desiree
Cesaro, Simone
Ziino, Ottavio
Zanazzo, Giulio
Manicone, Rosaria
Livadiotti, Susanna
Cellini, Monica
Frenos, Stefano
Milano, Giuseppe M.
Cappelli, Barbara
Licciardello, Maria
Beretta, Chiara
Arico, Maurizio
Castagnola, Elio
[J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (09): : 1612 - 1615
[9] European Centre for Disease Prevention and Control, GEOGR DISTR ANT CONS
[10] European Centre for Disease Prevention and Control, SUMM LAT DAT ANT RES

← 1 2 3 4 →